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Hepatocyte nuclear factor-6 (HNF-6) is a liver-enriched transcription factor that contains a single cut domain and a novel 
type of homeodomain. Here we have studied the developmental expression pattern of HNF-6 in the mouse. /n  situ hybridiza- 
tion experiments howed that HNF-6 mRNA is detected in the liver at embryonic day (E) 9, at the onset of liver differentia- 
tion. HNF-6 mRNA disappeared transiently from the liver between E12.5 and E15. In trandection experiments HNF-6 
stimulated the expression of HNF-4 and of HNF-3/], two transcription factors known to be involved in liver development 
and differentiation. HNF-6 was detected in the pancreas from E10.5 onward, where it was restricted to the exocrine cells. 
HNF-6 was also detected in the developing nervous system. Both the brain and the spinal cord started to express HNF-6 
at E9-9.5 in postmitotic neuroblasts. Later on, HNF-6 was restricted to brain nuclei, to the retina, to the ventral horn of 
the spinal cord, and to dorsal root ganglia. Our observations that HNF-6 contributes to the control of the expression of 
transcription factors and is expressed at early stages of liver, pancreas, and neuronal differentiation suggest that HNF.6 
regulates several developmental programs. © 1997 Academic Press 
INTRODUCTION 
Tissue-specific transcription factors play a key role in 
restricting ene expression to particular tissues in the adult 
organism. They also often participate to establishing the 
differentiated phenotype during embryogenesis. Thus, liver- 
enriched transcription factors can regulate both the expres- 
sion of liver proteins and the development of hepatic tissue 
{for review see Lai and Darneli, 19911. Moreover, several 
of these transcription factors individually control multiple 
developmental events in space and in time during fetal ife, 
as a single factor can be expressed, sometimes with different 
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time courses, in different cell lineages. Five families of liver- 
enriched transcription factors have been well characterized 
[for review see Cereghlni, 1996). They include the leucine 
zipper CCAAT/enhancer-binding proteins, the proline- and 
acid-rich leucine zipper proteins, the homeodomain-con- 
taining hepatocyte nuclear factor (HNF)-1, the winged helix 
proteins HNF-3 a, /3, and % and the zinc finger orphan 
receptor HNF-4. We have recently cloned from rat liver a 
novel transcription factor, termdd HNF-6, that contains a
bipartite DNA-binding region consisting of a single cut do- 
main and a highly distinctive homeodomain (Lemaigre t 
al., 1996). This factor corresponds to a DNA-binding activ- 
ity called LP4 by Lemaigre t al. (1993}. As demonstrated 
below, it is also identical to the DNA-binding activity called 
HNF-6 by Samadani and Costa (1996}. HNF-6 was originally 
characterized asa transcriptional activator of liver 6-phos- 
phofructo-2-kinase, an enzyme whose product, fructose 2,6- 
bisphosphate, controls glycolysis and gluconeogenesis {for 
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reviews see Rousseau and Hue, 1993, and Lemaigre and 
Rousseau, 1994}. HNF-1 {Pontoglio et al., 1996}, HNF-3fl 
{Ang and Rossant, 1994; Weinstein et al., 1994) and HNF- 
4 {Chen et al., 1994) have essential developmental func- 
tions, as shown by the embryonic {HNF-3B and HNF-4) or 
perinatal (HNF-1} mortality of the corresponding homozy- 
gous knock-out mice {for review see Cereghini, 1996}. HNF- 
6 belongs to the superclass of cut domain-containing ho- 
meoproteins, which include the Drosophila cut protein and 
the products of the mammal ian mClox gene. The cut pro- 
tein participates in determining cell fate in developing sen- 
sory organs and malpighian tubules {Bodmer et al., 1987; 
Blochlinger et al., 1988; Liu and Jack, 1992}. The mClox 
gene products are possible regulators of cell fate specifica- 
tion in several differentiation programs {Andres et al., 1992; 
Quaggin et al., 1996). This prompted us to investigate the 
possible role of HNF-6 in development. As a first step we 
have examined its pattern of expression in the embryonic 
mouse. Here we show that HNF-6 expression is initiated 
in the liver at the onset of liver differentiation. In addition, 
we demonstrate in transfection experiments that HNF-6 
can transactivate he HNF-3fl and HNF-4 genes, two genes 
that are also expressed at the onset of liver development 
and whose products are components of the cross-regulatory 
network of liver-enriched transcription activators {for re- 
views see Sladek and Damell, 1992, and Cereghini, 1996}. 
Furthermore, our in situ hybridization data suggest an 
involvement of HNF-6 in pancreatic and neuronal differen- 
tiation. 
MATERIALS AND METHODS 
Tissue preparation. Embryos were obtained from matings be- 
tween NMRI mice. Pregnant females at various stages of gestation 
were killed by cervical dislocation. The day of appearance of the 
vaginal plug was counted as E0.5. For late embryonic stages (E15, 
E17, and El8) embryos were removed from the uterine horns, dis- 
sected from their extraembryonic membranes, and peffused by left 
ventricular puncture/right atrial incision with 4% para.formalde- 
hyde in 0.1 M phosphate-buffered saline, pH 7.4 (PBS}. For earlier 
embryonic stages {E7-12.5), embryos were dissected and directly 
immersed in 4% paraformaldehyde without perfusion. The em- 
bryos were then fixed at 4"C overnight in 4% paraformaldehyde, 
washed in PBS, dehydrated, and stored at -200C in 70% ethanol. 
In situ hybridization. For radioactive in situ hybridization, 
dehydrated embryos were cleared in toluene, embedded in paraf- 
fin, and serially sectioned 16 /am}. [asS]UTP-labeled single- 
stranded sense and antisense HNF-6 riboprobes were prepared 
by standard procedures [Melton et al., 19841 from a 427-bp rat 
HNF-6 cDNA fragment subcloned in pBluescript (Stratagenel. 
These probes span nucleotides 721-1147 and exclude the cut 
domain and the homeodomain as well as the polyhistidine 
stretch [Lemaigre t al., 19961. They are 98.6% identical to the 
corresponding region of the mouse HNF-6 eDNA [R. Costa, per- 
sonal communication]. Specific signals seen with the antisense 
probe were not seen with the sense probe. Hybridizations were 
performed as described by Wilkinson [19921 and modified by Pi- 
card et al. [1997). For detection of the signal, the slides were 
dipped in Kodak NTB-2 emulsion and exposed for 3 to 4 weeks. 
The tissues were stained with Harris hematoxylin and counter- 
stained with lithium carbonate. Nonradioactive in situ hybrid- 
ization was performed on whole embryos as described byWilkin- 
son [1992]. After this, embryos were embedded in a mixture [9:1, 
v/v} of 0.5% gelatin, 38% egg albumin, 20% sucrose, and of glu- 
taraldehyde and cut (vibratome) at 50/am. Pictures were taken 
using a Zeiss Photomicroscope 11 or a Zeiss binocular SV-6 con- 
nected by IVC video camera to a PC Delta I computer running 
a CorelDRAW software {Lux Optic, Belgium]. 
Plasmids. pHNF3flluc contains the rat HNF-3fl gene promoter 
[-179 to +641 subcloned in pGL2 (Promega}. pHNF3flmutluc is 
identical to pHNF3filuc with the exception that the 5'-ATATTG- 
A IITI-I-III~-3 ' sequence [-137 to -123} of the promoter was 
replaced by 5'-GAGTACTGTCCTCCG-3' via PCR-directed muta- 
genesis to disrupt he HNF-6 binding site. pHNF4 0.71uc contains 
the mouse HNF-4 gene promoter (-554 to + 159) subcloned inpGL3 
basic (Promega]. In pHNF4 0.7mutluc nucleotides -383 to -376 
(5'-AAGTCAAT-3') of the HNF-4 promoter were mutated in 5'- 
AAGcttcg-3' {mutated nucleotides are in lower case letters] using 
PCR to disrupt the HNF-6 site by introducing a H/ndI~ site. 
pRL-138 contains the PFK-2 liver promoter [-138 to +87] cloned 
upstream of the Renilla luciferase coding sequences, pECE- 
HNF6Acut/hd codes for amino acids 1 to 284 of HNF-6. pECE- 
HNF6 was described inLemaigre t al. [1996], and pRL-CMV [cod- 
ing for Renilla luciferase] and pGEM-3 were from Promega. 
Antibodies. Anti-HNF-6 antibodies were obtained after injec- 
tion of rabbits with recombinant glutathione-S-transferase {GST)- 
HNF-6 coupled to keyhole limpet hemocyanin and mixed with 
Freund's adjuvant. GST-HNF-6 contains the GST residues fused 
to amino acids 111 to 465 of rat HNF-6 and was expressed in Esche- 
ricbAa coli. Immunoglobulins were precipitated from immune and 
preimmune serum by ammonium sulfate. 
Electrophoretic mobility shift assays (EMSA). EMSA with rat 
liver nuclear extracts or with in vitro translated HNF-6 were per- 
formed as described [Lemaigre et al., 1993, 19961 using the follow- 
ing 32P-labeled double-stranded oligonucleotides: oligo HNF-4p, 5'- 
AGGATAGAAGTCAATGATCTGGGA-3' [-390 to -367 of the 
mouse HNF-4 promoterl, oligo HNF-3flp, 5'-AGCTTAAGGCCC- 
GATATTGA~CTCC-3 '  {-150 to -118 of the rat 
HNF-3B promoter], oligo PFK-IV, 5'-gatcGCTTTGAAATTGAT- 
TTCAAAGC-3' {-195 to -216 of the rat 6-phosphofructo-2-kinase 
liver promoter]. Competing oligonucleotides or antibodies were 
added to the incubation mixture 30 rain prior to addition of the 
a2P-labeled probe. 
Cell culture and transfection. Rat-1 fibroblasts and human 
hepatoma HepG2 cells were grown i  Dulbecco's modified Eagle 
medium {DMEM} supplemented with 10% fetal calf serum {FCS]. 
Rat hepatoma FTO-2B cells were grown in DMEM/Ham's FI2 
medium supplemented with 10% FCS. Rat-1 cells 13 × l0 s cells 
per 60-ram dish] were transfected overnight in medium without 
FCS by lipofection using DOTAP, 2.5 /ag pHNF3Dluc or 
pHNF3flmutluc reporter construct, 50 ng pECE-HNF6, 50 ng 
pRL-CMV internal control, and 2.4/ag pGEM-3 to adjust plasmid 
amounts to 5 /ag. The cells were washed with PBS and further 
incubated for 24 h in DMEM plus 10% FCS before measuring 
luciferase activities with the Dual-Luciferase kit (Promega). 
HepG2 ceils were transfected using the same protocol as for Rat- 
1 cells, with the exception that 7 × l0 s cells were used and that 
plasmid amounts were 2.5/~g pHNF4 0.71uc or pHNF4 0.7mutluc 
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FIG. 1. Biphasic expression of the HNF-6 gene during mouse liver organogenesis. Bright-field [left panels) and dark-field {right panels) 
images show tissue sections of paraffin-embedded mbryos hybridized with the aSS-labeled HNF-6 RNA probe. At E9.5 HNF-6 mRNA 
was abundant in the liver diverticulum [A and B) and in the liver primordium [C and D). HNF-6 signals were absent from the liver at 
E12.5 (E and F) but were again present at El5 {G and HI. See text for details, d, liver diverticulum; fg, foregnt! li, liver; p, liver primordium. 
Original objectives were x25 for A-F  and x40 for G and H. 
reporter, 250 ng pECE-HNF6, 25 ng pRL-CMV, and 2.225 /ag 
pGEM-3. When comparing the activities of pHNF4 0.71uc and 
pHNF4 0.7mutluc, the cells were transfected with 8/zg luciferase 
reporter and 2/~g pRL-138 internal control. FTO-2B cells were 
transfected with the calcium phosphate coprecipitation method 
as described (Lemaigre et  a l . ,  1996} using 8 #g pHNF3Bluc or 
pHNF3Bmutluc and 2 /~g pRL-CMV. Luciferase activities were 
measured with a Lumac luminometer and expressed as the ratio 
of reporter activity {firefly luciferase] to internal control activity 
(Renilla lueiferase). ' 
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FIG. 2. Expression of the HNF-6 gene in the mouse fetal gall bladder and pancreas. Sections obtained from embryos at E12.5 (A-D}, E15 
{E and F) and E18 {G and H) were hybridized with the 3SS-labeled HNF-6 RNA probe and photographed under bright-field {left panels] and 
dark-field (right panels) illumination. (A-DI The HNF-6 gene was expressed in the gall bladder (A and B] and pancreatic (C and D} 
primordia. {C-H} HNF-6 gene expression was associated with the exocrine pancreas and absent from the islets of Langerhans {arrows} as 
seen in panels G and H. See text for details, gb, gall bladder; p, pancreas. Original objectives were x40 for A-D and x 10 for E-H. 
FIG. 3. Expression of the HNF-6 gene in the mouse fetal nervous system• Sections obtained from embryos at El0.5 (A-H} and El7 Il- 
L) were hybridized with the oss-labeled HNF-6 RNA probe and photographed under bright-field {left panels] and dark-field [right panelsl 
illumination. Distribution of HNF-6 mRNA in the dorsal and ventral parts of the mesencephalon (A and B}, the ventral part of the 
hindbrain {C and D}, the diencephalon (C, D, G, and H} and the telencephalon {E and F} where it was expressed in the olfactory lobe and 
not in the nasal pit [F is a higher magnification of the olfactory lobe seen in E}. In the diencephalon, HNF-6 gene expression was observed 
within the neuroepithelium facing the optic pit (G and H are higher magnifications of this region pointed out in C and D}. In the neural 
tube, HNF-6 mRNA was restricted to the mantle layer and absent from the ventricular zone (A-H). At El7, HNF-6 mRNA was present 
in the retina {arrows in I and JI and in nuclei of the pons and of the mesencephalon (K and LI. HNF-6 mRNA was also present in the 
trigeminal ganglion (K and L]. c, cerebellum; d, diencephalon; h, hindbrain; m, mesencephalon; ml, mantle layer; n, nasal pit; p, pons; t, 
telencephalon; tg, trigeminal ganglion; vz, ventrictrlar zone. See text for details. Original objectives were x l0  for A and B, x3.2 for C and 
D, x l:6.for E, x40 for F-H, x5 for I and J, and x2 for K and L. 
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FIG. 4. Expression of the HNF-6 gene through the cephalocaudal xis of the mouse spinal cord and in the dorsal root ganglia as detected 
by (A and B) the digoxigenin-labeled HNF-6 RNA probe and {C-FI the 3SS-labeled HNF-6 RNA probe• (A) Lateral view of a whole-mount 
embryo at E10.5 and IB) transverse section through a whole-mount embryo at E9.5. IC and DI HNF-6 was present in the dorsal and ventral 
mantle layer within the spinal cord at ElO.5. Note that at EIO.S a relatively small proportion of the mantle layer is present in the alar 
plate {the future dorsal gray columnl, whereas the basal plate {the future ventral gray hornJ is quite voluminous• (E and F) At E1S HNF- 
6 mRNA was restricted to the ventral horn. See text for details• The white arrow in A points to the labeling of HNF-6 mRNA within the 
pancreas and the liver, c, cloaca; drg, dorsal roo~ ganglion; ml, mantle layer. Original objectives were x3 for A, x5 for B, xlO for C and 
D, and x6.3 for E and F. 
i 
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RESULTS 
Expression of HNF:6 in Derivatives 
of the Endoderm 
We first performed/n situ hybridizations with the ass- 
labeled HNF-6 sense and antisense riboprobes on serial par- 
affin sections of embryos embedded in the decidua at E7 
and E8.5. HNF-6 mRNA was detected neither in the embryo 
nor in the extraembryonic t ssues. The onset of HNF-6 gene 
transcription was detected at E9 both in the nervous system 
{see below) and in derivatives of the endoderm. 
In the primitive gut and its derivatives, expression of the 
FINF-6 gene was first detected by whole-mount/n situ hybrid- 
ization at E9 and further analyzed at later stages by/n  situ 
hybridization performed on paraffin sections with the ass_h. 
beled probes. At E9.5, .HNF-6 gene expression was observed in 
the liver diverticulum {Figs. 1A and 1B) located at the foregut- 
midgut junction. This diverticulum grows into the septum 
transversum anal gives rise to the biliary system and to the 
liver primordium. At that stage, HNF-6 mRNA was also de- 
tected in the liver primordium within the septum transver- 
sum {Figs. 1C and 1D). As discussed below, the time of appear- 
anch of HNF-6 at he foregut-midgut j nction correlates with 
the onset of liver development. Interestingly, HNF-6 mRNA 
was no longer detected in the liver at E12.5 {Figs. 1E and 1F} 
but was again clearly present at E15 {Figs. 1G and 1H}, E17, 
and E18 {data not shown}. Thus, HNF-6 gene expression was 
biphasic during liver development. 
The HNF-6 gene was expressed in the biliary system which, 
like the liver, originates from the ventral endodermal lining 
of the gut. At E12.5, HNF-6 mRNA was abundant in the gall 
bladder primordium {Figs. 2A and 2B). The HNF-6 gene was 
expressed in the pancreas. The earliest pancreatic HNF-6 ex- 
pression was seen by whole-mount in situ hybridization at 
El0.5 {arrow in Fig. 4A). At later stages, the pancreatic expres- 
sion of the HNF-6 gene was analyzed on paraffin sections 
{Figs. 2C-2H). At E12.5, HNF-6 mRNA was abundant in the 
pancreatic pfimordia {Figs. 2C and 2D} and this persisted in 
embryos at El5 and El8 {Figs. 2E-2H). At E18, the HNF-6 
signal was absent from the islets of Langerhans {Figs. 2G and 
2H}, i.e., endocrine pancreas, which can first be identified his- 
tologicaUy around E16 {Kaufinan, 1995). Therefore, it is the 
exocrine pancreas that expresses HNF-6. 
From E9 to Ell ,  the HNF-6 gene was highly but tran- 
siently expressed in two regions of the gut, namely the fore- 
gut-midgut junction {see above} and the hindgut {Fig. 4A). 
Expression in the hindgut was confirmed by/n situ hybrid- 
ization with the aSS-labeled probe {data not shown). No 
HNF-6 signal was seen in the simple columnar epithelium 
of the foregut {Figs. 1A and 1B). From E12.5 onward, no 
HNF-6 mRNA was detected in any parts of the gut. Thus, 
expression of the HNF-6 gene in the primitive gut was 
highly restricted in time and in space. This contrasts with 
the other liver-enriched transcription factors which are 
widely expressed in the developing ut [Blumenfeld et al., 
1991; Ang et al., 1993; Duncan et al., 1994}. 
Expression of BNF-6 in the Developing Nervous 
System 
Whole-mount experiments showed that HNF-6 mRNA 
first appeared at E9 within the developing nervous ystem. 
The distribution of HNF-6 mRNA in the cephalic regions 
was analyzed at El0.5 by /n  situ hybridization performed 
on serial paraffin sections with the 3SS-labeled probes. HNF- 
6 gene expression was seen in the forebrain, midbrain, and 
hindbrain [Figs. 3A-3H}. In these structures HNF-6 was 
exclusively expressed within the mantle layer where post- 
mitotic neuroblasts are located {Figs. 3A-3H). Along the 
dorsoventral xis of the neural tube, the HNF-6 signal was 
restricted to the ventral half of the rhombencephalon while 
it was seen over the whole mantle layer of the mesencepha- 
Ion (Figs. 3A-3D}. The floor plate and the notochord id 
not express HNF-6. Within the neuroepithelium of the dien- 
cephalon and of the telencephalon, HNF-6 mRNA was de- 
tected in regionally restricted areas facing the optic vesicle 
and the nasal pit, respectively [Figs. 3E-3H). In the dien- 
cephalon HNF-6 mRNA was abundant in a very limited 
zone where the two primary lateral evaginations, i.e., the 
optic stalks, arise [Figs. 3G and 3H}, but was absent from 
the optic stalks. In the telencephalon, HNF-6 gene xpres- 
sion was detected in the developing olfactory lobes that 
will in due course receive sensory information from the 
olfactory epithelium {Figs. 3E and 3F}. 
At later stages, HNF-6 was still expressed in the devel- 
oping brain. By E16, the orderly structure within the origi- 
nal three layers, i.e., the ependymal, mantle, and marginal 
layers, is lost in favor of differentiation i to special central 
nervous system nuclei (Rugh, 1993). Accordingly, at E17, 
HNF-6 was detected in several nuclei of the mesencephalon 
and of the pons {Figs. 3K and 3L} and of the medulla oblon- 
gata {data not shown}. As early as E9 and later, the trigemi- 
nal {Figs. 3K and 3LJ and facial-acoustic ganglia were 
strongly labeled. Within the peripheral nervous system, 
HNF-6 mRNA was also detected in the retina at E17 {Figs. 
3I and 3J). Higher magnification of the retina showed that 
expression of HNF-6 was restricted to the ganglion cells 
layer {data not shown). 
At E9.5-10.5, whole-mount experiments showed that HNF- 
6 mRNA was found as a decreasing gradient along the cephalo- 
caudal axis of the spinal cord {Fig. 4A). Transverse sections 
through the whole-mount embryos showed that HNF-6 
mRNA was detected in the mantle layer of the spinal cord 
{Fig. 4B), as was observed in the brain. In situ hybridization 
experiments with the aSS-labeled HNF-6 probe indicated that 
at E10.5 HNF-6 gene expression was detected in the dorsal 
and ventral parts of the mantle layer {Figs. 4C and 4D), the 
mantle layer being at that stage wider ventrally than dorsally. 
The cephalocaudal and dorsoventral gradients of HNF-6 gene 
expression i the spinal cord then correlate with the gradients 
of neuronal differentiation along these two axes (Nomes and 
Carry, 1978}. At El5, HNF-6 mRNA distribution along the 
dorsoventral xis of the spinal cord changed and became re- 
stricted to the ventral hom while it disappeared from the 
Copyright © 1997 by Academic Press. All rights of reproduction in any form reserved. 
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dorsal hom (compare Figs. 4C, 4D and 4E, 4F). HNF-6 was 
expressed neither at the floor plate nor within the notocord. 
Finally, at all stages examined, HNF-6 expression was de- 
tected in the dorsal root ganglia [Figs. 4B-4F). 
HNF-6 Stimulates the Expression of HNF-3IJ 
and HNF-4 
Our in situ hybridization data raised the question of the 
nature of the HNF-6 target genes during development. One 
candidate was the HNF-3fl gene, which is expressed during 
liver organogenesis [Monaghan et t., 1993; Sasaki and Ho- 
gan, 1993}. The HNF-3]3 promoter contains aputative bind- 
ing site for HNF-6, i.e., {-1281 AAATCAATAT 1-137) 
(Lemaigre t al., 1996). We verified whether HNF-6 binds 
to this promoter. Footprinting experiments showed that re- 
combinant HNF-6 indeed protected this binding site against 
digestion by DNase I {data not shown}. Binding of HNF- 
6 to a probe corresponding to the footprinted region was 
confirmed by EMSA with liver nuclear extracts. We de- 
tected a specific protein-DNA complex {closed arrow in 
Fig. 5A, lanes 1-3) whose appearance was prevented by an 
excess of oligo PFK-IV, which corresponds to the original 
HNF-6 binding site found in the promoter of the 6-phospho- 
fructo-2-kinase g ne (Fig. 5A, lane 4) and by the addition of 
anti-HNF-6 antiserum {Fig. 5A, lanes 5 and 6). This complex 
comigrated with the complex of in vitro synthesized recom- 
binant HNF-6 bound to the HNF-3fl probe {Fig. 5A, lane 71. 
These data therefore demonstrated that HNF-6 binds to the 
HNF-3B promoter. They extend those of Samadani and 
Costa {1996} by identifying the protein involved in the 
DNA-protein complex that these authors described on the 
same site of the HNF-3B promoter. The HNF-3~ probe used 
in our EMSA also bound other proteins responsible for 
weaker protein-DNA complexes (open arrowheads in Fig. 
5AI. This HNF-3fl gene region contributed to 80% of pro- 
moter activity in our transfection experiments with hepa- 
toma FTO-2B cells (Fig. 5C), consistent with the data ob- 
tained by Samadani and Costa {1996). To test the functional 
consequences of the interaction of HNF-6 with this se- 
quence, we cotransfected a HNF-6 expression vector and a 
luciferase reporter construct driven by the HNF-3fl pro- 
moter in a cell line devoid of HNF-6, namely Rat-1 fibro- 
blasts. Overexpression of HNF-6 stimulated the HNF-3fl 
promoter 2.5-fold, while overexpression f a HNF-6 mutant 
devoid of DNA-binding domain (HNF-6Acut/hd) did not 
influence promoter activity {Fig. 5D). 
Another potential target of HNF-6 was the HNF-4 gene, 
which like HNF-6 and HNF-3fl is also expressed uring 
liver organogenesis {Duncan et al., 1994; Taraviras et al., 
19941. Indeed, DNase I footprinting experiments with re- 
combinant HNF-6 demonstrated a specific protection on 
the HNF-4 promoter around nucleotide -380 relative to the 
transcription i itiation site (not shown). The gene sequence 
there is indeed compatible with a HNF-6 binding site, i.e., 
{-383) AAGTCAATGA {-374}. We tested this site in 
EMSA with liver nuclear extracts {Fig. 5B). This showed a 
major complex (arrow} that was specific {Fig. 5B, lanes 1- 
3J and was prevented by an excess of oligo PFK-IV. Also, 
the formation of this complex was inhibited by the addition 
of anti-HNF-6 antiserum {Fig. 5B, lanes 5 and 61. Minor 
complexes prevented by this immune serum correspond to 
degradation products of HNF-6. Finally, in vitro synthe- 
sized recombinant HNF-6 bound to the HNF-4 probe comi- 
grated with the major complex seen with the liver extracts 
{Fig. 5B, lane 71. These data therefore demonstrated that 
HNF-6 binds to the HNF-4 promoter. The functional role 
of HNF-6 was tested by transfecting hepatoma HepG2 cells. 
Rat-1 cells could not be used because the HNF-4 promoter 
was not functional in these cells. Mutation of the HNF-6 
site in the HNF-4 promoter educed the activity of the 
promoter by 43% {Fig. 5C). Furthermore, cotransfection f 
the HNF-4 promoter-luciferase construct with a HNF-6 
expression vector led to a 2.4-fold increase in promoter 
activity, while overexpression f a HNF-6 mutant devoid 
of DNA-binding domain (HNF-6Acut/hd) did not influence 
this activity. We concluded from these experiments that 
HNF-6 binds to and stimulates the activity of the HNF-3fl 
and HNF-4 promoters. 
D ISCUSSION 
We have shown here that the HNF-6 gene is expressed in 
several cell lineages during embryonic and fetal develop- 
ment. The earliest expression of HNF-6 was detected at 
E9 in the primitive gut and in the nervous ystems. Liver 
ontogeny has been well described at the cellular level (Le 
Douarin, 1975; Houssaint, 1981), but its genetic ontrol is 
less documented. Recent data by Hentsch et al. (19961 indi- 
cate that liver organogenesis proceeds by stepwise inductive 
interactions that are under separate genetic control. The 
commitment of the endodermal cells to a hepatic fate oc- 
curs at E8 and it is controlled by signals produced by the 
cardiogenic mesoderm ILe Douarin, 1975; Houssaint, 1981; 
Cascio and Zaret, 1991; Gualdi et al., 1996}. This takes place 
at a presomite stage when HNF-6 is not yet expressed. The 
onset of HNF-6 expression at E9 in fact correlates with the 
onset of liver development, i.e., proliferation and differenti- 
ation of hepatic endoderm into hepatoblasts. Indeed, at E9- 
9.5 cells from the ventral endoderm at the foregut-midgut 
junction start to proliferate and to differentiate oform the 
liver diverticulum and the liver primordium that develops 
within the septum transversum. This is also concomitant 
with the onset of HNF-4 expression i  the fetal liver {Dun- 
can et al., 1994; Taraviras et al., 19941. HNF-4 is an essential 
transcription factor for hepatic ~lifferentiation as demon- 
strated by its capacity to redifferentiate dedifferentiated 
hepatoma cells (Kuo et al., 1992; Griffo et al., 1993; Sp~th 
and Weiss, 19971. The finding that HNF-6 binds to and acti- 
vates the HNF-4 gene, combined with the concomitant ex- 
pression of HNF-6 and HNF-4 in the liver, suggests that 
HNF-6 plays a role at the onset of liver development. 
Our protein-DNA interaction and transfection data also 
g 
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FIG. 5. HNF-6 binds to and activates the HNF-33 and HNF-4 genes. EMSA with a probe derived from (AI the HNF-33 gene promoter 
(oligo HNF-33p} or (BI the HNF-4 gene promoter {oligo HNF-4p} in the presence of liver nuclear extract (liver} or of HNF-6-producing 
wheat germ extract Iwg), with or without competing oligonucleotides or immune serum against HNF-6, as indicated. (CI Relative luciferase 
activity of the constructs driven by the wild-type (pHNF331ucl or mutated (pHNF33mutluc} HNF-33 promoter after transfection in 
hepatoma FTO-2B cells. (D) Fold stimulation of the HNF-33 promoter IpHNF331uc) in Rat-1 flbroblasts by cotransfected wild-type { ECE- 
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showed that HNF-6 stimulates HNF-3fl expression. During 
liver development HNF-6 {this paper) and HNF-3fl 
(Monaghan et al., 1993} are highly expressed at E9 but be- 
come undetectable at E12.5 and reappear at El5. The reap- 
pearance of these transcription factors coincides with the 
further differentiation of the hepatic cells that occurs at 
E14-16 (Schmid et al., 1991; for review see Xanthopoulos 
and Mirkovitch, 1993}. At that time, more hepatoblasts be- 
come hepatocytes and this process will continue until the 
liver is fully differentiated. Thus, in addition to their puta- 
tive role at early stages of liver development, HNF-6 and 
HNF-3/3 might control the later steps of differentiation i to 
the adult phenotype. 
Liver-enriched transcription factors form a cross-regula- 
tory network that controls the expression of genes in the 
liver (Tian and Schibler, 1991; Kuo et al., 1992; for review 
see Cereghini, 1996). We have shown here that HNF-6 con- 
tributes to the control of the HNF-4 and HNF-3/3 genes, 
whose protein products are known to stimulate transcrip- 
tion of the HNF-1 gene. HNF-6 might therefore participate 
to this network. In addition, our data have potential impli- 
cations for human physiopathology. Indeed, mutations of 
the HNF-1 a (Yamagata et al., 1996a) and HNF-4 {Yamagata 
et al., 1996b)genes are associated,with maturity-onset dia- 
betes of the young in heterozygote humans. Thus, abnormal 
HNF-6 structure or expression could perturb expression of 
HNF-4 and HNF-1 and therefore also play a role in such 
disease states. 
HNF-6 gene expression was first detected once the pan- 
creatic primordia have emerged from the endodermal lining 
of the gut (E10.5) and it was maintained in the pancreas 
during fetal development. This suggests a role for HNF-6 in 
pancreatic gene expression. We have found putative HNF- 
6 binding sites in the a-amylase gene promoter, which is 
therefore acandidate target gene for HNF-6. HNF-6 expres- 
sion in the pancreas precedes a-amylase xpression as the 
latter is detected at El2 by PCR IGittes and Rutter, 1992) 
and at E15 by in situ hybridization (Petrucco et al., 1990 I. 
Thus HNF-6 would require the combinatorial effect of other 
transcription factors that appear around E 12-E 15, e.g., PTF 1 
(Petrucco et aI., 1990), to initiate a-amylase gene expres- 
sion. 
Our analysis of HNF-6 gene expression in the nervous 
system revealed three noteworthy features. First, HNF-6 
appears in the neural tube at E9-9.5. Second, along the 
mediolateral xis, the HNF-6 gene is expressed in the man- 
tle layer. Third, the distribution of HNF-6 along the dorso- 
ventral axis is dependent on the developmental stage. Al- 
though different ypes of neurons form at different imes, 
neurogenesis, i.e., the neuroblast birth, occurs at E9-9.5 in 
the spinal cord and the brain stem and this largely precedes 
gliogenesis (Rodier, 1980). In mammals, the neuroblasts are 
postmitotic ells that originate from mitotic progenitors 
strictly located in the ventricular zone. The postmitotic 
neuroblasts hen migrate along the mediolateral xis toward 
the mantle layer. We have shown here that HNF-6 gene 
expression is detected within the mantle layer and is absent 
from the ventricular zone. The latter zone specifically ex- 
presses Notch ligands and different groups of transcription 
factors such as the basic-helix-loop-helix (bHLHI proteins 
and the paired homeoproteins {for review see Tanabe and 
Jessel, 1996). Recently, a novel paired-homeodomain pro- 
rein, PDH1, was shown to be expressed in a narrow layer 
adjacent o the ventricular zone (Saito et al., 1996}. Thus, 
discrete regions along the mediolateral axis of the spinal 
cord are defined by the expression of different classes of 
transcription factors which might act sequentially to pro- 
gressively specify the identity of the neuron. In line with 
these observations, the cut-homeoprotein HNF-6 could act 
downstream ofthe neurogenic program active in the progen- 
itor cells {within the ventricular zone} as it is expressed in 
neuroblasts once they have settled down in the mantle 
layer. In addition to the controlled expression of HNF-6 
along the mediolateral xis, our observations suggest hat 
additional signaling steps are involved in the control of 
HNF-6 gene expression at later stages in spinal cord devel- 
opment. Indeed, at El0.5, HNF-6 signals were seen in both 
the dorsal and ventral parts of the spinal cord, while at 
E15 this expression became restricted to the ventral part. 
Finally, the spatiotemporal expression of HNF-6 in the de- 
veloping spinal cord suggests that HNF-6 could be involved 
in morphogenesis a well as in cell type specification. 
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